DHR

Q: What is the price of Danaher (DHR) today?

The price of Danaher (DHR) today is $ 209.50, with return of 0.28% compared to the last year. The price of Danaher (DHR) started the year trading around $ 228.92 and today it is at $ 209.50. Follow the real-time price chart, the historical price of Danaher (DHR) and international markets.

Q: When does Danaher (DHR) pay dividends?

In the last year, Danaher (DHR) distributed dividends in the month of January, totaling $ 0.32. The Dividend Yield for the last 12 months is 0.61%.

Q: Is Danaher (DHR) worth it?

Currently, Danaher (DHR) is priced at $ 209.50, with a P/E of 40.98%, representing a deviation of 3,658% from its historical average P/E. In the last year, the stock showed a variation of 0.28 in its price and distributed $ 0.32 in dividends, resulting in a Dividend Yield of 0.61%. The total shareholder return was 0.28%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How can I buy Danaher (DHR) stock?

Investing in stocks of Danaher (DHR) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much would 100 shares of Danaher (DHR) yield today?

The yield of Danaher (DHR) was -10.73% in the last month, 0.28% in the last year and -3.96% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of $ 1.28 in dividends, with a Dividend Yield of 0.61%.If you wanted to buy 100 stocks of Danaher (DHR) today, the total investment would be $ 20,950.00, based on the current price of $ 209.50.If past performance were to repeat, the return on your investment would be:In 1 year: $ 21,008.66In 5 years: $ 20,120.38In 10 years: $ 51,826.11It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Danaher Corporation

Price

$ 209.50

return (12m)

0.28%

p/e

40.98

p/b

2.82

DIVIDEND YIELD

0.61%

price DHR

DHR

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return of DHR

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-10.73%

3 months

-7.57%

1 year

0.28%

2 years

-16.59%

5 years

-3.96%

10 years

147.38%

Fundamentals DHR

review the fundamentals of Danaher shares

P/E

40.98

Sector: -2.14 Industry: -5.77

P/S (Price-to-Sales)

6.03

Sector: 2.06 Industry: 3.26

P/B

2.82

Sector: 2.34 Industry: 2.48

DIVIDEND YIELD (DY)

0.61%

Sector: - Industry: -

ROA

4.33%

Sector: -27.16% Industry: -52.92%

ROE

6.88%

Sector: -30.98% Industry: -45.34%

ROIC

7.18%

Sector: -421.19% Industry: -486.73%

NET MARGIN

14.71%

Sector: -29.07% Industry: -35.11%

GROSS MARGIN

59.11%

Sector: 44.34% Industry: 46.27%

OPERATING MARGIN

19.09%

Sector: -24.62% Industry: -30.73%

EV/EBITDA

21.33

Sector: -0.57 Industry: -4.16

EV/EBIT

32.93

Sector: -2.98 Industry: -5.86

PRICE-TO-ASSETS

1.77

Sector: 1.23 Industry: 1.46

BVPS

74.32

Sector: 3.47 Industry: 1.66

EPS

5.11

Sector: -0.90 Industry: -1.31

EQUITY-TO-ASSETS RATIO

0.63

Sector: 0.42 Industry: 0.46

LIABILITIES / ASSETS

0.37

Sector: 0.46 Industry: 0.43

CAGR REVENUE 5 YEARS

-3.56%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

-10.43%

Sector: - Industry: -

FAIR VALUE OF Danaher ASSETS ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffet's mentor.

Current price

$ 209.50

Fair Value

$ 0.00

Upside Return potential.

-55.88%

See Graham's ranking

Because it considers equity value in its calculation, the formula does not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals DHR

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/b	ROE	dy	market cap	net margin
LLY	43.78	37.88	86.53%	0.59%	$ 903.52 B	31.66%
ISRG	62.65	9.97	15.92%	0.00%	$ 178.94 B	28.38%
TMO	28.66	3.59	12.52%	0.34%	$ 192.11 B	15.05%
SNY	12.51	1.36	10.86%	4.73%	$ 114.14 B	18.68%
NVS	21.85	6.56	30.04%	2.43%	$ 305.57 B	24.67%
ABT	29.61	3.77	12.73%	2.12%	$ 193.15 B	14.72%
MDT	26.07	2.58	9.90%	2.92%	$ 124.17 B	13.71%
GSK	15.56	5.56	35.71%	2.82%	$ 118.68 B	17.48%
CVS	55.09	1.29	2.35%	3.47%	$ 97.40 B	0.44%
BSX	38.16	0.00	0.00%	0.00%	$ 110.60 B	14.44%
TMDX	49.74	12.85	25.84%	0.00%	$ 4.56 B	16.20%
HCA	17.89	-43.80	-244.82%	0.54%	$ 121.36 B	8.97%
IDXX	48.00	31.68	65.99%	0.00%	$ 50.85 B	24.62%
RMD	25.46	5.99	23.51%	0.87%	$ 37.83 B	27.53%
INMD	10.22	1.40	13.73%	0.00%	$ 958.86 M	25.32%
FMS	17.45	0.87	5.00%	3.23%	$ 14.24 B	3.73%
PHG	27.73	2.24	8.06%	2.93%	$ 28.76 B	5.07%
SYK	44.76	6.48	14.48%	0.90%	$ 145.29 B	12.92%
CI	10.85	0.00	0.00%	2.15%	$ 74.56 B	2.50%

Stock vs Index Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

DHR Historical Dividends

current DY: 0.61%

5-year average DY: 0.43%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividend	12/26/2025	01/30/2026	0,32000000
Dividend	09/26/2025	10/31/2025	0,32000000
Dividend	06/27/2025	07/25/2025	0,32000000
Dividend	03/28/2025	04/25/2025	0,32000000
Dividend	12/27/2024	01/31/2025	0,27000000
Dividend	09/27/2024	10/25/2024	0,27000000
Dividend	06/28/2024	07/26/2024	0,27000000
Dividend	03/28/2024	04/26/2024	0,27000000
Dividend	12/29/2023	01/26/2024	0,24000000
Dividend	10/12/2023	10/27/2023	0,27000000
Dividend	06/30/2023	07/28/2023	0,27000000
Dividend	03/31/2023	04/28/2023	0,27000000
Dividend	12/30/2022	01/27/2023	0,25000000
Dividend	09/30/2022	10/28/2022	0,25000000
Dividend	06/24/2022	07/29/2022	0,25000000
Dividend	03/25/2022	04/29/2022	0,25000000
Dividend	12/30/2021	01/28/2022	0,21000000
Dividend	09/30/2021	10/29/2021	0,21000000
Dividend	06/25/2021	07/30/2021	0,21000000
Dividend	03/26/2021	04/30/2021	0,21000000
Dividend	12/28/2020	01/29/2021	0,18000000
Dividend	09/28/2020	10/30/2020	0,18000000
Dividend	06/26/2020	07/31/2020	0,18000000
Dividend	03/27/2020	04/24/2020	0,18000000
Dividend	12/27/2019	01/31/2020	0,17000000
Dividend	09/27/2019	10/25/2019	0,17000000
Dividend	06/28/2019	07/26/2019	0,17000000
Dividend	03/29/2019	04/26/2019	0,17000000
Dividend	12/28/2018	01/25/2019	0,16000000
Dividend	09/28/2018	10/26/2018	0,16000000
Dividend	06/29/2018	07/27/2018	0,16000000
Dividend	03/29/2018	04/27/2018	0,16000000
Dividend	12/29/2017	01/26/2018	0,14000000
Dividend	09/29/2017	10/27/2017	0,14000000
Dividend	06/30/2017	07/28/2017	0,14000000
Dividend	03/31/2017	04/28/2017	0,14000000
Dividend	12/30/2016	01/27/2017	0,12500000
Dividend	09/30/2016	10/28/2016	0,12500000
Dividend	06/03/2016	07/29/2016	0,16000000
Dividend	03/24/2016	04/29/2016	0,16000000
Dividend	12/21/2015	01/29/2016	0,13490000
Dividend	10/02/2015	10/30/2015	0,13490000
Dividend	06/26/2015	07/31/2015	0,13490000
Dividend	03/27/2015	04/24/2015	0,13490000
Dividend	12/26/2014	01/30/2015	0,10000000
Dividend	09/26/2014	10/31/2014	0,10000000
Dividend	06/27/2014	07/25/2014	0,10000000
Dividend	03/28/2014	04/25/2014	0,10000000
Dividend	12/30/2013	01/31/2014	0,02490000
Dividend	09/27/2013	10/25/2013	0,02490000
Dividend	06/28/2013	07/26/2013	0,02490000
Dividend	03/28/2013	04/26/2013	0,02490000
Dividend	12/14/2012	12/28/2012	0,02490000
Dividend	09/28/2012	10/26/2012	0,02490000
Dividend	06/29/2012	07/27/2012	0,02490000
Dividend	03/30/2012	04/27/2012	0,02490000
Dividend	12/30/2011	01/27/2012	0,02490000
Dividend	09/30/2011	10/28/2011	0,02490000
Dividend	06/24/2011	07/29/2011	0,02000000
Dividend	03/25/2011	04/29/2011	0,02000000
Dividend	12/31/2010	01/28/2011	0,02000000
Dividend	09/24/2010	10/29/2010	0,02000000
Dividend	06/25/2010	07/30/2010	0,02000000
Dividend	03/26/2010	04/30/2010	0,02005000
Dividend	12/31/2009	01/29/2010	0,02005000
Dividend	09/25/2009	10/30/2009	0,01505000
Dividend	06/26/2009	07/31/2009	0,01505000
Dividend	03/27/2009	04/24/2009	0,01505000
Dividend	12/26/2008	01/30/2009	0,01505000
Dividend	09/26/2008	10/31/2008	0,01505000
Dividend	06/27/2008	07/25/2008	0,01505000
Dividend	03/28/2008	04/25/2008	0,01505000
Dividend	12/31/2007	01/25/2008	0,01505000
Dividend	09/28/2007	10/26/2007	0,01505000
Dividend	06/29/2007	07/27/2007	0,01505000
Dividend	03/30/2007	04/27/2007	0,01000000
Dividend	12/29/2006	01/26/2007	0,01000000
Dividend	09/29/2006	10/27/2006	0,01000000
Dividend	06/30/2006	07/28/2006	0,01000000
Dividend	03/31/2006	04/28/2006	0,01000000
Dividend	12/31/2005	01/27/2006	0,01000000
Dividend	09/30/2005	10/28/2005	0,01000000
Dividend	06/24/2005	07/29/2005	0,00750000
Dividend	03/25/2005	04/29/2005	0,00750000
Dividend	12/31/2004	01/28/2005	0,00750000
Dividend	09/24/2004	10/29/2004	0,00750000
Dividend	06/25/2004	07/30/2004	0,00750000
Dividend	03/26/2004	04/30/2004	0,00620000
Dividend	12/26/2003	01/30/2004	0,00620000
Dividend	09/26/2003	10/31/2003	0,00620000
Dividend	06/27/2003	07/31/2003	0,00620000
Dividend	03/28/2003	04/30/2003	0,00620000
Dividend	12/27/2002	01/31/2003	0,00620000
Dividend	09/27/2002	10/31/2002	0,00620000
Dividend	06/28/2002	07/31/2002	0,00500000
Dividend	03/29/2002	04/30/2002	0,00500000
Dividend	12/28/2001	01/31/2002	0,00500000
Dividend	09/28/2001	10/31/2001	0,00500000
Dividend	06/29/2001	07/31/2001	0,00500000
Dividend	03/30/2001	04/27/2001	0,00500000
Dividend	12/29/2000	01/31/2001	0,00500000
Dividend	09/29/2000	10/31/2000	0,00500000
Dividend	06/30/2000	07/31/2000	0,00370000
Dividend	03/31/2000	04/28/2000	0,00370000
Dividend	12/31/1999	01/31/2000	0,00370000
Dividend	09/24/1999	10/29/1999	0,00370000
Dividend	06/25/1999	07/30/1999	0,00370000
Dividend	03/26/1999	04/30/1999	0,00370000
Dividend	12/24/1998	01/29/1999	0,00370000
Dividend	09/25/1998	10/30/1998	0,00370000
Dividend	06/26/1998	07/31/1998	0,00317500
Dividend	03/20/1998	04/24/1998	0,00316250
Dividend	12/26/1997	01/23/1998	0,00316250
Dividend	09/26/1997	10/31/1997	0,00316250
Dividend	06/27/1997	07/25/1997	0,00316250
Dividend	03/21/1997	04/25/1997	0,00316250
Dividend	12/27/1996	01/24/1997	0,00316250
Dividend	09/27/1996	10/25/1996	0,00316250
Dividend	06/27/1996	07/26/1996	0,00250000
Dividend	03/22/1996	04/26/1996	0,00250000
Dividend	12/28/1995	01/26/1996	0,00250000
Dividend	09/28/1995	10/27/1995	0,00250000
Dividend	06/30/1995	07/28/1995	0,00250000
Dividend	03/27/1995	04/28/1995	0,00250000
Dividend	12/16/1994	01/20/1995	0,00250625
Dividend	09/26/1994	10/28/1994	0,00185000
Dividend	06/24/1994	07/29/1994	0,00185000
Dividend	03/23/1994	04/29/1994	0,00185000
Dividend	12/17/1993	01/21/1994	0,00185000
Dividend	09/29/1993	10/29/1993	0,00185000
Dividend	06/25/1993	07/16/1993	0,00185000
Dividend	03/26/1993	04/16/1993	0,00185000

ABOUT THE COMPANY Danaher

Danaher Corporation

Average user rating I10

4.0 (24 people)

United States

40 years

Founded: 1986

1986

Time since IPO - 40 years

80.000

Employees

Danaher Corporation operates within the healthcare and technology sectors, with activities in the life sciences, diagnostics and laboratory equipment subsectors. Its shares are traded on the New York Stock Exchange (NYSE) under the ticker DHR. The company was founded by Steven and Mitchell Rales, driven by the objective of building an industrial conglomerate focused on continuous innovation and operational excellence grounded in standardized management systems.

Its core products and services include clinical diagnostic systems, laboratory instruments, bioprocessing solutions, molecular analysis technologies, precision measurement tools, scientific research equipment and platforms used in the manufacturing of biological therapies. These offerings serve hospitals, laboratories, biopharmaceutical manufacturers, universities and research institutions.

Danaher’s addressable market is global, with commercial presence in North America, Europe, Asia-Pacific, the Middle East and Latin America. Operations support demand across healthcare, pharmaceuticals, biotechnology, industrial monitoring and scientific research, with established market share in countries such as the United States, Germany, the United Kingdom, China and Japan.

Relevant market drivers include rising demand for advanced clinical diagnostics, expansion of the biopharmaceutical industry, increasing need for automated laboratory solutions, higher R&D investments, stringent healthcare regulatory standards and competition from global manufacturers of laboratory equipment and consumables. Technological trends such as continuous bioprocessing, laboratory digitalization and biological therapy development shape the company’s innovation and growth strategy.

Danaher’s operational scale includes tens of thousands of employees, hundreds of manufacturing sites and research facilities, and thousands of corporate and institutional clients. Its activities span global production of equipment, technical support services, integration of laboratory platforms and international distribution.

The company’s operating structure comprises its headquarters in Washington, D.C., divisions dedicated to diagnostics, life sciences and environmental solutions, manufacturing hubs across multiple countries, biotechnology research units and innovation laboratories. Logistics rely on complex supply chains, industrial technology integration and global service coverage for corporate clients.

Danaher’s operating model is built on the Danaher Business System (DBS), a proprietary framework for continuous improvement, operational efficiency, process standardization and data-driven innovation. Core practices include lean management, digital integration, total quality programs and specialized technical support. The primary trading ticker is DHR on the NYSE.

History and Foundation

Danaher was founded in 1984 in Washington, D.C., with the objective of consolidating a diversified industrial group built on efficient operating processes and a portfolio centered on high-precision technologies.

In its early years, the company faced challenges related to expanding its portfolio through strategic acquisitions, implementing the DBS operating system and strengthening synergies across business units. Initial achievements included reinforcing its industrial divisions and gaining operational scale.

A subsequent expansion cycle was driven by entry into clinical diagnostics, life sciences and health-technology segments through acquisitions of leading companies in biotechnology, bioanalytics and laboratory solutions. This period also marked broader geographic reach, with operations and customers across both developed and emerging markets.

Historical milestones include its 1984 initial public offering (IPO) and major acquisitions such as Leica Microsystems (2005), Beckman Coulter (2011) and Pall Corporation (2015). Other key events include the spinoff of Fortive Corporation in 2016 and the separation of Veralto Corporation in 2023, reshaping the strategic portfolio toward healthcare and life sciences.

Between 2020 and 2024, relevant developments included rising global demand for diagnostics and laboratory solutions, expansion in bioprocessing operations, investments in technologies supporting biological therapy production, adjustments to the corporate structure following strategic reorganizations and ongoing evolution of the company’s competitive position within the global life sciences market. These factors influenced operational performance and business dynamics throughout the period.

Additional Information

The Company Danaher Corporation (United States), is listed on NYSE with a market value of $ 148.12 Billions, having an equity of $ 52.54 Billions.

With a total of 80.000 employees, the company is listed in the sector of Health and categorized in industry of Life Science Tools and Services.

In the last 12 months the Company had a revenue of $ 24.57 Billions, which generated a profit in the amount of $ 3.61 Billions.

As for its main indicators, the Company has a P/E ratio of 40.98, a P/BV ratio of 2.82 and in the last 12 months the dividend yield of DHR was at 0.61%.

The Company is traded internationally through the ticker DHR.

Market cap

$ 148.12 Billions

Net worth

$ 52.54 Billions

US$ 52,541,000,000.00

Assets

$ 83.46 Billions

US$ 83,464,000,000.00

Total Shares Outstanding

707.00 Millions

707,000,000

Average Daily Trading Volume

$ 3.94 Millions

US$ 3,939,320.00

Sector

Health

Industry

Life Science Tools and Services

DHR

businesses that generate revenue for Danaher

Regions where Danaher generates revenue

DHR revenue and profits

Financial Results DHR

DRAG THE FRAME TO SEE MORE DATA

DHR cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

LBPSW - 4D pharma

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-300.00%

P/B

0.00

CVS - CVS Health

$ 76.69 25,42% (12M)

P/E

55.09

3.47%

ROE

2.35%

P/B

1.29

CI - Cigna

$ 280.31 --4,05% (12M)

P/E

10.85

2.15%

ROE

0.00%

P/B

0.00

CNC - Centene

$ 43.24 --25,03% (12M)

P/E

-3.19

0.00%

ROE

-33.28%

P/B

1.06

HUM - Humana

$ 189.83 --24,43% (12M)

P/E

17.64

1.86%

ROE

6.95%

P/B

1.23

HCA - HCA Healthcare

$ 532.30 69,76% (12M)

P/E

17.89

0.54%

ROE

-244.82%

P/B

-43.80

LLY - Eli Lilly

$ 1,009.52 15,58% (12M)

P/E

43.78

0.59%

ROE

86.53%

P/B

37.88

NVS - Novartis

$ 162.67 57,11% (12M)

P/E

21.85

2.43%

ROE

30.04%

P/B

6.56

LBPSW - 4D pharma

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-300.00%

P/VP

0.00

CVS - CVS Health

$ 76.69 25,42% (12 M)

P/L

55.09

3.47%

ROE

2.35%

P/VP

1.29

CI - Cigna

$ 280.31 --4,05% (12 M)

P/L

10.85

2.15%

ROE

0.00%

P/VP

0.00

CNC - Centene

$ 43.24 --25,03% (12 M)

P/L

-3.19

0.00%

ROE

-33.28%

P/VP

1.06

HUM - Humana

$ 189.83 --24,43% (12 M)

P/L

17.64

1.86%

ROE

6.95%

P/VP

1.23

HCA - HCA Healthcare

$ 532.30 69,76% (12 M)

P/L

17.89

0.54%

ROE

-244.82%

P/VP

-43.80

LLY - Eli Lilly

$ 1,009.52 15,58% (12 M)

P/L

43.78

0.59%

ROE

86.53%

P/VP

37.88

NVS - Novartis

$ 162.67 57,11% (12 M)

P/L

21.85

2.43%

ROE

30.04%

P/VP

6.56

Frequently Asked Questions

What is the price of Danaher (DHR) today?

The price of Danaher (DHR) today is $ 209.50, with return of 0.28% compared to the last year. The price of Danaher (DHR) started the year trading around $ 228.92 and today it is at $ 209.50. Follow the real-time price chart, the historical price of Danaher (DHR) and international markets.

When does Danaher (DHR) pay dividends?

In the last year, Danaher (DHR) distributed dividends in the month of January, totaling $ 0.32. The Dividend Yield for the last 12 months is 0.61%.

Is Danaher (DHR) worth it?

Currently, Danaher (DHR) is priced at $ 209.50, with a P/E of 40.98%, representing a deviation of 3,658% from its historical average P/E. In the last year, the stock showed a variation of 0.28 in its price and distributed $ 0.32 in dividends, resulting in a Dividend Yield of 0.61%. The total shareholder return was 0.28%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How can I buy Danaher (DHR) stock?

Investing in stocks of Danaher (DHR) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much would 100 shares of Danaher (DHR) yield today?

The yield of Danaher (DHR) was -10.73% in the last month, 0.28% in the last year and -3.96% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of $ 1.28 in dividends, with a Dividend Yield of 0.61%.

If you wanted to buy 100 stocks of Danaher (DHR) today, the total investment would be $ 20,950.00, based on the current price of $ 209.50.

If past performance were to repeat, the return on your investment would be:

In 1 year: $ 21,008.66
In 5 years: $ 20,120.38
In 10 years: $ 51,826.11

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

DHR

Danaher Corporation

Price

return (12m)

p/e

p/b

DIVIDEND YIELD

Return of DHR

review the fundamentals of Danaher shares

P/E

P/S (Price-to-Sales)

P/B

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

EV/EBITDA

EV/EBIT

PRICE-TO-ASSETS

BVPS

EPS

EQUITY-TO-ASSETS RATIO

LIABILITIES / ASSETS

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

Graham's Fair Value

If you had invested (change) 2 years years ago, ago, you would now have

current DY: 0.61%

5-year average DY: 0.43%

type

Ex - Dividend Date

payment date

value

ABOUT THE COMPANY Danaher

Danaher Corporation

United States

40 years

1986

80.000

History and Foundation

Additional Information

PROFIT X PRICE DHR

Financial Results DHR

DHR cash flow

asset growth - DHR

DHR balance sheet

LBPSW - 4D pharma

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

HCA - HCA Healthcare

LLY - Eli Lilly

NVS - Novartis

LBPSW - 4D pharma

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

HCA - HCA Healthcare

LLY - Eli Lilly

NVS - Novartis

Frequently Asked Questions